Korean J Thorac Cardiovasc Surg.  1997 Mar;30(3):330-335.

Pulmonary Aspergillosis in Cardiac Transplant Patients: The Report of Two Cases

Affiliations
  • 1Sejong Heart Institute, Sejong General Hospital, Puchon-shi, Korea.

Abstract

Aspergillus Infection is a major cause of mortality in individuals with depressed cell-mediated immunity. Despite therapy with intravenous amphotericin B and oral antifungal agents, high mortality has been reported among heart transplant recipients. We experienced two cases of pulmonary aspergillosis among 15 cases of heart transplantation cases. Both cases were similiar in terms of age, time of diagnosis, diagnosis, and medication. Percutaneous needle aspiration biopsy revealed Aspergillus fumigatus in both cases. The first case showed multiple aspergilloma on both lung fields and were treated by IV Amphotericin B and oral itraconazole. After completion of treatment, the lesion completely disappeared and he has been followed up for more than one year in his good condition. The second case showed a single nodule on his right lower lung field and were treated by both medication and surgery. The patient recovered well and had been doing well until 4th postoperative month when he developed humoral rejection and expired.

Keyword

Heart transplantation; Aspergillosis

MeSH Terms

Amphotericin B
Antifungal Agents
Aspergillosis
Aspergillus
Aspergillus fumigatus
Biopsy, Needle
Diagnosis
Heart
Heart Transplantation
Humans
Immunity, Cellular
Itraconazole
Lung
Mortality
Needles
Pulmonary Aspergillosis*
Transplantation
Amphotericin B
Antifungal Agents
Itraconazole
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr